HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[CO(2) laser vaporisation of actinic cheilitis].

Abstract
As a premalignant condition, actinic cheilitis requires therapy, and multiple treatment modalities have been described. Although frequently reported in Angloamerican literature, CO(2) laser vaporization for the treatment of actinic cheilitis is scarcely mentioned in German journals. We report 19 cases of CO(2) laser treatment of actinic cheilitis. In only one case, the ablation proved to be too superficial after the first treatment. Except in this case we did not see any recurrences and only one case with minor scarring within a median follow up period of 16 months. In comparison with other treatment modalities, we consider the CO(2) laser ablation to be a safe and cost-saving method with excellent cosmetic results.
AuthorsS Hohenleutner, M Landthaler, U Hohenleutner
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 50 Issue 8 Pg. 562-5 (Aug 1999) ISSN: 0017-8470 [Print] Germany
Vernacular TitleCO(2)-Laservaporisation der Cheilitis actinica.
PMID10460299 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Carcinoma, Squamous Cell (pathology, surgery)
  • Cheilitis (pathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Laser Therapy
  • Lip (pathology, surgery)
  • Lip Neoplasms (pathology, surgery)
  • Male
  • Middle Aged
  • Neoplasms, Radiation-Induced (pathology, surgery)
  • Precancerous Conditions (pathology, surgery)
  • Treatment Outcome
  • Ultraviolet Rays (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: